A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumor growth reduction in vivo

L Bagella, A Sun, T Tonini, G Abbadessa, G Cottone, M G Paggi, A De Luca, P P Claudio, A Giordano
  • Oncogene, October 2006, Springer Science + Business Media
  • DOI: 10.1038/sj.onc.1209987

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1038/sj.onc.1209987

The following have contributed to this page: Marco Paggi